http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014062228-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_680dd0699e3f4ba8532d128c7152b3bb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40 |
| filingDate | 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd22df1155a8571f905f4a23bc79d07c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcea80744a476ed5e519b6fc4e708633 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2075035e1b6b6f1f42f427cb2eb139ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa86869a82f0a2cfda39c0f6bcda1121 |
| publicationDate | 2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014062228-A1 |
| titleOfInvention | An improved nanovector based drug delivery system for overcoming drug resistance |
| abstract | Various embodiments of the present invention provide therapeutic compositions for specifically targeting tumor cells. In some embodiments, the therapeutic compositions generally include: (1) a plurality of nanovectors; (2) one or more active agents associated with the nanovectors, where the one or more active agents have activity against the tumor cells; (3) one or more active agent enhancers associated with the nanovectors; and (4) one or more targeting agents associated with the nanovectors, where the one or more targeting agents have recognition activity for one or more markers of the tumor cells. Additional embodiments of the present invention pertain to methods of targeting tumor cells in a subject by administering one or more of the aforementioned therapeutic compositions to the subject. Further embodiments of the present invention pertain to methods of formulating the aforementioned therapeutic compositions for targeting tumor cells in a subject in a personalized manner. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543232-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016098562-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108017623-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298376-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540439-B2 |
| priorityDate | 2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 134.